Menu

Breakthrough Prizes for Life Scientists

Awards of $3 million each go to five researchers in the life sciences, recognizing their pioneering work on autophagy, DNA-damage response, Wnt signaling, and more.

Dec 5, 2016
Tracy Vence

Roeland Nusse accepts a Breakthrough Prize.TWITTER, STANFORD MEDICINEStephen Elledge of Harvard Medical School, the University of California, Santa Cruz’s Harry Noller, Roeland Nusse of Stanford University, Yoshinori Ohsumi of Tokyo Institute of Technology, and Huda Zoghbi of Baylor College of Medicine have won 2017 Breakthrough Prizes in Life Sciences. Each award, given yesterday (December 4) during a televised ceremony held in California, is worth $3 million.

Elledge is honored for his pioneering work on DNA-damage response. In 2015, he won a Lasker Award for basic medical research in recognition of his achievements in the field. “I’m truly honored to receive the Breakthrough Prize,” Elledge said in a statement. “It is deeply gratifying to see the profound impact that basic research can have not only in promoting scientific knowledge but also in improving human health.”

Noller is recognized “for discovering the centrality of RNA in forming the active centers of the ribosome,” according to the Breakthrough Prize announcement.

Nusse is honored for his work on Wnt signaling. “This is a complete surprise,” Nusse said in a press release. “My gratitude goes out to many people — my past and present postdoctoral scholars and graduate students and my former mentors have all contributed to the success of my research.”

Ohsumi, who this year won the Nobel Prize in Physiology or Medicine for his pioneering autophagy research, has won a Breakthrough Prize in recognition of his achievements in the field. In 2012, he won a Kyoto Prize in Basic Sciences.

Zoghbi is honored “for discoveries of the genetic causes and biochemical mechanisms of spinocerebellar ataxia and Rett syndrome, findings that have provided insight into the pathogenesis of neurodegenerative and neurological diseases,” according to the announcement. This year she won a Shaw Prize in Life Science and Medicine. “Sometimes rare diseases can really teach you something that's very helpful for more common diseases whose development and treatment has been elusive,” Zoghbi said during the Breakthrough Prize ceremony, according to The Washington Post.

Now in their fifth year, the Breakthrough Prizes are awarded annually to highlight achievements in the life sciences, mathematics, physics, and education. Winners are chosen by selection committees made up of previous Breakthrough Prize laureates.

“There has never been a more important time to support science,” Breakthrough Prize cofounder Mark Zuckerberg, chief executive officer of Facebook, said in the prize announcement. 

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing